This case illustrates different growth strategies in the pharmaceutical industry. R&D management is a critical component of growth strategies, and the case demonstrates the importance of using a holistic framework for R&D when expanding the firm's business footprint. The case serves the purpose of comparing organic and inorganic growth strategies, and identifying the steps that are critical for the execution of these strategies.
The case can be used in either a 90-minute MBA class discussion or a 4-hour executive class discussion on the topics of Supply Chain Management, R&D Management, or Strategic Management. The key issue is the linkage between the strategy of growth and the execution skills needed to implement the strategy. The case discusses business model innovation at length, and compares different processes needed to innovate successfully
- R&D Management
- Supply Chain Management
- Growth Management
- Mergers and Acquisitions
- Healthcare Industry
